Recent Finacing
Recent Raise
Adcendo is a clinical-stage biotechnology company developing first- and potential best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
